7 completed, 2 terminated, 1 withdrawn. 5 Phase 2, 3 Not applicable, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Withdrawn 1 |
| Not applicable | 3 | Completed 2, Terminated 1 |
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Beyond Air Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Efficacy of UNO - Ultra High Concentration Nitric Oxide Injection in Combination With PD-1 Inhibitors Into Unresectable Solid Primary or Metastatic Tumors Nitric Oxide 25,000 ppm, Nitric Oxide 50,000 ppm - Cancer | Phase 1 | Terminated | Beyond Air Inc. | 38 | 2022-08-14 | 2026-10-13 |
| A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients LungFit - Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis | Not applicable | Completed | Beyond Air Inc. | 15 | 2020-12-07 | 2022-12-16 |
| Inhaled NO for the Treatment of Viral Pneumonia in Adults LungFit™ - Viral Pneumonia, Nitric Oxide | Not applicable | Completed | Beyond Air Inc. | 40 | 2020-11-25 | 2022-12-16 |
| Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial) 150 ppm Nitric Oxide delivered through LungFit Delivery System, 80 ppm Nitric Oxide delivered through LungFit Delivery System - COVID-19, SARS-CoV 2 | Phase 2 | Withdrawn | Beyond Air Inc. | 2020-07-15 | 2021-01-22 | |
| Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) Nitric Oxide delivered via LungFit™ system - Corona Virus Infection, COVID-19 | Not applicable | Terminated | Beyond Air Inc. | 4 | 2020-06-13 | 2022-12-16 |
| Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With Bronchiolitis Nitric Oxide, Standard Supportive treatment - Bronchiolitis Acute | Phase 2 | Completed | Beyond Air Inc. | 95 | 2019-11-06 | 2020-05-12 |
| Inhaled Nitric Oxide for Patients With MABSC Nitric Oxide - Mycobacterium Abscessus Infection | Phase 2 | Completed | Beyond Air Inc. | 9 | 2017-07-24 | 2019-07-09 |
| Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis Nitric Oxide, Supportive treatment - Bronchiolitis | Phase 3 | Completed | Beyond Air Inc. | 69 | 2017-03-05 | 2019-07-09 |
| Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis Nitric oxide - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | Beyond Air Inc. | 9 | 2013-12-01 | 2016-06-03 |
| Evaluation of the Safety and Tolerability of Nitric Oxide (NO) Via Inhalation to Subjects With Bronchiolitis Nitric Oxide, Placebo - Bronchiolitis | Phase 1 / Phase 2 | Completed | Beyond Air Inc. | 43 | 2013-01-01 | 2016-05-04 |
COVID-19 (3) · Pneumonia, Viral (3) · Respiration Disorders (3) · Bronchiolitis (2) · Coronavirus Infections (2) · Cystic Fibrosis (2) · Mycobacterium Infections, Nontuberculous (2) · Respiratory Aspiration (2) · Severe Acute Respiratory Syndrome (2) · Virus Diseases (2) · Mycobacterium avium-intracellulare Infection (1) · Neoplasms (1)
Nitric Oxide (5) · Palliative Care (1)
Israel (7) · Australia (1) · United States (1)
Asher Tal, M.D (2) · Asher Tal (1) · Asher Tal, MD (1) · Ashik Tal, MD (1) · Aviv Goldbart (1) · David Greenberg, MD (1) · Hannah Blau, M.D (1)